Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin 15
SEC filing record 1 source field available
Fiscal year end
31 December
Keenova Therapeutics plc has filed 1,415 SEC EDGAR filings since 01 Feb 2013

SEC filing history

Showing 1-25 of 1,000 matching filings.

Per page
25
Current page
1
SD File 001-35803

FORM SD

Filing date
29 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-87833

SCHEDULE 13D/A filing

Filing date
22 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 May 2026
Reporting date
19 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87833

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-35803

ARS

Filing date
27 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35803

DEF 14A

Filing date
27 Apr 2026
Reporting date
02 Jun 2026
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Apr 2026
Reporting date
23 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Apr 2026
Reporting date
23 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Apr 2026
Reporting date
23 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-87833

SCHEDULE 13D/A filing

Filing date
17 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Apr 2026
Reporting date
15 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-35803

PRE 14A

Filing date
13 Apr 2026
Reporting date
02 Jun 2026
Next action
Verify source filing
NT 10-K File 001-35803

NT 10-K

Filing date
01 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .